Global and Japan Fibroblast Growth Factor Receptor 4 Market Insights, Forecast to 2026

Publisher Name :
Date: 28-Oct-2020
No. of pages: 140
Inquire Before Buying

Fibroblast Growth Factor Receptor 4 market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Fibroblast Growth Factor Receptor 4 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Fibroblast Growth Factor Receptor 4 market is segmented into

- BLU-9931

- BMS-986036

- Erdafitinib

- ES-135

- FGF-401

- Others

Segment by Application, the Fibroblast Growth Factor Receptor 4 market is segmented into

- Breast Cancer

- Lymphoma

- Melanoma

- Fallopian Tube Cancer

- Lung Cancer

- Others

Regional and Country-level Analysis

The Fibroblast Growth Factor Receptor 4 market is analysed and market size information is provided by regions (countries).

The key regions covered in the Fibroblast Growth Factor Receptor 4 market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Fibroblast Growth Factor Receptor 4 Market Share Analysis

Fibroblast Growth Factor Receptor 4 market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Fibroblast Growth Factor Receptor 4 business, the date to enter into the Fibroblast Growth Factor Receptor 4 market, Fibroblast Growth Factor Receptor 4 product introduction, recent developments, etc.

The major vendors covered:

- Amgen Inc

- ArQule Inc

- AstraZeneca Plc

- Blueprint Medicines Corp

- Bristol-Myers Squibb Co

- Eisai Co Ltd

- Eli Lilly and Co

- Genosco Inc

- H3 Biomedicine Inc

- Incyte Corp

- Ionis Pharmaceuticals Inc

- Johnson & Johnson

- Merrimack Pharmaceuticals Inc

- NGM Biopharmaceuticals Inc

- Novartis AG

- Principia Biopharma Inc

- Tasly Pharmaceutical Group Co Ltd

- Vichem Chemie Research Ltd

Global and Japan Fibroblast Growth Factor Receptor 4 Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Fibroblast Growth Factor Receptor 4 Product Introduction
1.2 Market Segments
1.3 Key Fibroblast Growth Factor Receptor 4 Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Fibroblast Growth Factor Receptor 4 Market Size Growth Rate by Type
1.4.2 BLU-9931
1.4.3 BMS-986036
1.4.4 Erdafitinib
1.4.5 ES-135
1.4.6 FGF-401
1.4.7 Others
1.5 Market by Application
1.5.1 Global Fibroblast Growth Factor Receptor 4 Market Size Growth Rate by Application
1.5.2 Breast Cancer
1.5.3 Lymphoma
1.5.4 Melanoma
1.5.5 Fallopian Tube Cancer
1.5.6 Lung Cancer
1.5.7 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Fibroblast Growth Factor Receptor 4 Market Size, Estimates and Forecasts
2.1.1 Global Fibroblast Growth Factor Receptor 4 Revenue 2015-2026
2.1.2 Global Fibroblast Growth Factor Receptor 4 Sales 2015-2026
2.2 Global Fibroblast Growth Factor Receptor 4, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Fibroblast Growth Factor Receptor 4 Historical Market Size by Region (2015-2020)
2.3.1 Global Fibroblast Growth Factor Receptor 4 Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Fibroblast Growth Factor Receptor 4 Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Fibroblast Growth Factor Receptor 4 Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Fibroblast Growth Factor Receptor 4 Sales Forecast by Region (2021-2026)
2.4.2 Global Fibroblast Growth Factor Receptor 4 Revenue Forecast by Region (2021-2026)
3 Global Fibroblast Growth Factor Receptor 4 Competitor Landscape by Players
3.1 Global Top Fibroblast Growth Factor Receptor 4 Sales by Manufacturers
3.1.1 Global Fibroblast Growth Factor Receptor 4 Sales by Manufacturers (2015-2020)
3.1.2 Global Fibroblast Growth Factor Receptor 4 Sales Market Share by Manufacturers (2015-2020)
3.2 Global Fibroblast Growth Factor Receptor 4 Manufacturers by Revenue
3.2.1 Global Fibroblast Growth Factor Receptor 4 Revenue by Manufacturers (2015-2020)
3.2.2 Global Fibroblast Growth Factor Receptor 4 Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Fibroblast Growth Factor Receptor 4 Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Fibroblast Growth Factor Receptor 4 Revenue in 2019
3.2.5 Global Fibroblast Growth Factor Receptor 4 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Fibroblast Growth Factor Receptor 4 Price by Manufacturers
3.4 Global Fibroblast Growth Factor Receptor 4 Manufacturing Base Distribution, Product Types
3.4.1 Fibroblast Growth Factor Receptor 4 Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Fibroblast Growth Factor Receptor 4 Product Type
3.4.3 Date of International Manufacturers Enter into Fibroblast Growth Factor Receptor 4 Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Fibroblast Growth Factor Receptor 4 Market Size by Type (2015-2020)
4.1.1 Global Fibroblast Growth Factor Receptor 4 Sales by Type (2015-2020)
4.1.2 Global Fibroblast Growth Factor Receptor 4 Revenue by Type (2015-2020)
4.1.3 Fibroblast Growth Factor Receptor 4 Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Fibroblast Growth Factor Receptor 4 Market Size Forecast by Type (2021-2026)
4.2.1 Global Fibroblast Growth Factor Receptor 4 Sales Forecast by Type (2021-2026)
4.2.2 Global Fibroblast Growth Factor Receptor 4 Revenue Forecast by Type (2021-2026)
4.2.3 Fibroblast Growth Factor Receptor 4 Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Fibroblast Growth Factor Receptor 4 Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Fibroblast Growth Factor Receptor 4 Market Size by Application (2015-2020)
5.1.1 Global Fibroblast Growth Factor Receptor 4 Sales by Application (2015-2020)
5.1.2 Global Fibroblast Growth Factor Receptor 4 Revenue by Application (2015-2020)
5.1.3 Fibroblast Growth Factor Receptor 4 Price by Application (2015-2020)
5.2 Fibroblast Growth Factor Receptor 4 Market Size Forecast by Application (2021-2026)
5.2.1 Global Fibroblast Growth Factor Receptor 4 Sales Forecast by Application (2021-2026)
5.2.2 Global Fibroblast Growth Factor Receptor 4 Revenue Forecast by Application (2021-2026)
5.2.3 Global Fibroblast Growth Factor Receptor 4 Price Forecast by Application (2021-2026)
6 Japan by Players, Type and Application
6.1 Japan Fibroblast Growth Factor Receptor 4 Market Size YoY Growth 2015-2026
6.1.1 Japan Fibroblast Growth Factor Receptor 4 Sales YoY Growth 2015-2026
6.1.2 Japan Fibroblast Growth Factor Receptor 4 Revenue YoY Growth 2015-2026
6.1.3 Japan Fibroblast Growth Factor Receptor 4 Market Share in Global Market 2015-2026
6.2 Japan Fibroblast Growth Factor Receptor 4 Market Size by Players (International and Local Players)
6.2.1 Japan Top Fibroblast Growth Factor Receptor 4 Players by Sales (2015-2020)
6.2.2 Japan Top Fibroblast Growth Factor Receptor 4 Players by Revenue (2015-2020)
6.3 Japan Fibroblast Growth Factor Receptor 4 Historic Market Review by Type (2015-2020)
6.3.1 Japan Fibroblast Growth Factor Receptor 4 Sales Market Share by Type (2015-2020)
6.3.2 Japan Fibroblast Growth Factor Receptor 4 Revenue Market Share by Type (2015-2020)
6.3.3 Japan Fibroblast Growth Factor Receptor 4 Price by Type (2015-2020)
6.4 Japan Fibroblast Growth Factor Receptor 4 Market Estimates and Forecasts by Type (2021-2026)
6.4.1 Japan Fibroblast Growth Factor Receptor 4 Sales Forecast by Type (2021-2026)
6.4.2 Japan Fibroblast Growth Factor Receptor 4 Revenue Forecast by Type (2021-2026)
6.4.3 Japan Fibroblast Growth Factor Receptor 4 Price Forecast by Type (2021-2026)
6.5 Japan Fibroblast Growth Factor Receptor 4 Historic Market Review by Application (2015-2020)
6.5.1 Japan Fibroblast Growth Factor Receptor 4 Sales Market Share by Application (2015-2020)
6.5.2 Japan Fibroblast Growth Factor Receptor 4 Revenue Market Share by Application (2015-2020)
6.5.3 Japan Fibroblast Growth Factor Receptor 4 Price by Application (2015-2020)
6.6 Japan Fibroblast Growth Factor Receptor 4 Market Estimates and Forecasts by Application (2021-2026)
6.6.1 Japan Fibroblast Growth Factor Receptor 4 Sales Forecast by Application (2021-2026)
6.6.2 Japan Fibroblast Growth Factor Receptor 4 Revenue Forecast by Application (2021-2026)
6.6.3 Japan Fibroblast Growth Factor Receptor 4 Price Forecast by Application (2021-2026)
7 North America
7.1 North America Fibroblast Growth Factor Receptor 4 Market Size YoY Growth 2015-2026
7.2 North America Fibroblast Growth Factor Receptor 4 Market Facts & Figures by Country
7.2.1 North America Fibroblast Growth Factor Receptor 4 Sales by Country (2015-2020)
7.2.2 North America Fibroblast Growth Factor Receptor 4 Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Fibroblast Growth Factor Receptor 4 Market Size YoY Growth 2015-2026
8.2 Europe Fibroblast Growth Factor Receptor 4 Market Facts & Figures by Country
8.2.1 Europe Fibroblast Growth Factor Receptor 4 Sales by Country
8.2.2 Europe Fibroblast Growth Factor Receptor 4 Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Fibroblast Growth Factor Receptor 4 Market Size YoY Growth 2015-2026
9.2 Asia Pacific Fibroblast Growth Factor Receptor 4 Market Facts & Figures by Country
9.2.1 Asia Pacific Fibroblast Growth Factor Receptor 4 Sales by Region (2015-2020)
9.2.2 Asia Pacific Fibroblast Growth Factor Receptor 4 Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Fibroblast Growth Factor Receptor 4 Market Size YoY Growth 2015-2026
10.2 Latin America Fibroblast Growth Factor Receptor 4 Market Facts & Figures by Country
10.2.1 Latin America Fibroblast Growth Factor Receptor 4 Sales by Country
10.2.2 Latin America Fibroblast Growth Factor Receptor 4 Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Fibroblast Growth Factor Receptor 4 Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Fibroblast Growth Factor Receptor 4 Market Facts & Figures by Country
11.2.1 Middle East and Africa Fibroblast Growth Factor Receptor 4 Sales by Country
11.2.2 Middle East and Africa Fibroblast Growth Factor Receptor 4 Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Amgen Inc
12.1.1 Amgen Inc Corporation Information
12.1.2 Amgen Inc Description and Business Overview
12.1.3 Amgen Inc Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Amgen Inc Fibroblast Growth Factor Receptor 4 Products Offered
12.1.5 Amgen Inc Recent Development
12.2 ArQule Inc
12.2.1 ArQule Inc Corporation Information
12.2.2 ArQule Inc Description and Business Overview
12.2.3 ArQule Inc Sales, Revenue and Gross Margin (2015-2020)
12.2.4 ArQule Inc Fibroblast Growth Factor Receptor 4 Products Offered
12.2.5 ArQule Inc Recent Development
12.3 AstraZeneca Plc
12.3.1 AstraZeneca Plc Corporation Information
12.3.2 AstraZeneca Plc Description and Business Overview
12.3.3 AstraZeneca Plc Sales, Revenue and Gross Margin (2015-2020)
12.3.4 AstraZeneca Plc Fibroblast Growth Factor Receptor 4 Products Offered
12.3.5 AstraZeneca Plc Recent Development
12.4 Blueprint Medicines Corp
12.4.1 Blueprint Medicines Corp Corporation Information
12.4.2 Blueprint Medicines Corp Description and Business Overview
12.4.3 Blueprint Medicines Corp Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Blueprint Medicines Corp Fibroblast Growth Factor Receptor 4 Products Offered
12.4.5 Blueprint Medicines Corp Recent Development
12.5 Bristol-Myers Squibb Co
12.5.1 Bristol-Myers Squibb Co Corporation Information
12.5.2 Bristol-Myers Squibb Co Description and Business Overview
12.5.3 Bristol-Myers Squibb Co Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Bristol-Myers Squibb Co Fibroblast Growth Factor Receptor 4 Products Offered
12.5.5 Bristol-Myers Squibb Co Recent Development
12.6 Eisai Co Ltd
12.6.1 Eisai Co Ltd Corporation Information
12.6.2 Eisai Co Ltd Description and Business Overview
12.6.3 Eisai Co Ltd Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Eisai Co Ltd Fibroblast Growth Factor Receptor 4 Products Offered
12.6.5 Eisai Co Ltd Recent Development
12.7 Eli Lilly and Co
12.7.1 Eli Lilly and Co Corporation Information
12.7.2 Eli Lilly and Co Description and Business Overview
12.7.3 Eli Lilly and Co Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Eli Lilly and Co Fibroblast Growth Factor Receptor 4 Products Offered
12.7.5 Eli Lilly and Co Recent Development
12.8 Genosco Inc
12.8.1 Genosco Inc Corporation Information
12.8.2 Genosco Inc Description and Business Overview
12.8.3 Genosco Inc Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Genosco Inc Fibroblast Growth Factor Receptor 4 Products Offered
12.8.5 Genosco Inc Recent Development
12.9 H3 Biomedicine Inc
12.9.1 H3 Biomedicine Inc Corporation Information
12.9.2 H3 Biomedicine Inc Description and Business Overview
12.9.3 H3 Biomedicine Inc Sales, Revenue and Gross Margin (2015-2020)
12.9.4 H3 Biomedicine Inc Fibroblast Growth Factor Receptor 4 Products Offered
12.9.5 H3 Biomedicine Inc Recent Development
12.10 Incyte Corp
12.10.1 Incyte Corp Corporation Information
12.10.2 Incyte Corp Description and Business Overview
12.10.3 Incyte Corp Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Incyte Corp Fibroblast Growth Factor Receptor 4 Products Offered
12.10.5 Incyte Corp Recent Development
12.11 Amgen Inc
12.11.1 Amgen Inc Corporation Information
12.11.2 Amgen Inc Description and Business Overview
12.11.3 Amgen Inc Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Amgen Inc Fibroblast Growth Factor Receptor 4 Products Offered
12.11.5 Amgen Inc Recent Development
12.12 Johnson & Johnson
12.12.1 Johnson & Johnson Corporation Information
12.12.2 Johnson & Johnson Description and Business Overview
12.12.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Johnson & Johnson Products Offered
12.12.5 Johnson & Johnson Recent Development
12.13 Merrimack Pharmaceuticals Inc
12.13.1 Merrimack Pharmaceuticals Inc Corporation Information
12.13.2 Merrimack Pharmaceuticals Inc Description and Business Overview
12.13.3 Merrimack Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Merrimack Pharmaceuticals Inc Products Offered
12.13.5 Merrimack Pharmaceuticals Inc Recent Development
12.14 NGM Biopharmaceuticals Inc
12.14.1 NGM Biopharmaceuticals Inc Corporation Information
12.14.2 NGM Biopharmaceuticals Inc Description and Business Overview
12.14.3 NGM Biopharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
12.14.4 NGM Biopharmaceuticals Inc Products Offered
12.14.5 NGM Biopharmaceuticals Inc Recent Development
12.15 Novartis AG
12.15.1 Novartis AG Corporation Information
12.15.2 Novartis AG Description and Business Overview
12.15.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Novartis AG Products Offered
12.15.5 Novartis AG Recent Development
12.16 Principia Biopharma Inc
12.16.1 Principia Biopharma Inc Corporation Information
12.16.2 Principia Biopharma Inc Description and Business Overview
12.16.3 Principia Biopharma Inc Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Principia Biopharma Inc Products Offered
12.16.5 Principia Biopharma Inc Recent Development
12.17 Tasly Pharmaceutical Group Co Ltd
12.17.1 Tasly Pharmaceutical Group Co Ltd Corporation Information
12.17.2 Tasly Pharmaceutical Group Co Ltd Description and Business Overview
12.17.3 Tasly Pharmaceutical Group Co Ltd Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Tasly Pharmaceutical Group Co Ltd Products Offered
12.17.5 Tasly Pharmaceutical Group Co Ltd Recent Development
12.18 Vichem Chemie Research Ltd
12.18.1 Vichem Chemie Research Ltd Corporation Information
12.18.2 Vichem Chemie Research Ltd Description and Business Overview
12.18.3 Vichem Chemie Research Ltd Sales, Revenue and Gross Margin (2015-2020)
12.18.4 Vichem Chemie Research Ltd Products Offered
12.18.5 Vichem Chemie Research Ltd Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Fibroblast Growth Factor Receptor 4 Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Fibroblast Growth Factor Receptor 4 Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Fibroblast Growth Factor Receptor 4 Market Segments
Table 2. Ranking of Global Top Fibroblast Growth Factor Receptor 4 Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Fibroblast Growth Factor Receptor 4 Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of BLU-9931
Table 5. Major Manufacturers of BMS-986036
Table 6. Major Manufacturers of Erdafitinib
Table 7. Major Manufacturers of ES-135
Table 8. Major Manufacturers of FGF-401
Table 9. Major Manufacturers of Others
Table 10. Global Fibroblast Growth Factor Receptor 4 Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 11. Global Fibroblast Growth Factor Receptor 4 Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 12. Global Fibroblast Growth Factor Receptor 4 Sales by Regions 2015-2020 (K Pcs)
Table 13. Global Fibroblast Growth Factor Receptor 4 Sales Market Share by Regions (2015-2020)
Table 14. Global Fibroblast Growth Factor Receptor 4 Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global Fibroblast Growth Factor Receptor 4 Sales Forecast by Region (2021-2026) (K Pcs)
Table 16. Global Fibroblast Growth Factor Receptor 4 Sales by Manufacturers (2015-2020) (K Pcs)
Table 17. Global Fibroblast Growth Factor Receptor 4 Sales Share by Manufacturers (2015-2020)
Table 18. Global Fibroblast Growth Factor Receptor 4 Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Fibroblast Growth Factor Receptor 4 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Fibroblast Growth Factor Receptor 4 as of 2019)
Table 20. Fibroblast Growth Factor Receptor 4 Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Fibroblast Growth Factor Receptor 4 Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Fibroblast Growth Factor Receptor 4 Price (2015-2020) (USD/Pcs)
Table 23. Fibroblast Growth Factor Receptor 4 Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Fibroblast Growth Factor Receptor 4 Product Type
Table 25. Date of International Manufacturers Enter into Fibroblast Growth Factor Receptor 4 Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Fibroblast Growth Factor Receptor 4 Sales by Type (2015-2020) (K Pcs)
Table 28. Global Fibroblast Growth Factor Receptor 4 Sales Share by Type (2015-2020)
Table 29. Global Fibroblast Growth Factor Receptor 4 Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Fibroblast Growth Factor Receptor 4 Revenue Share by Type (2015-2020)
Table 31. Fibroblast Growth Factor Receptor 4 Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 32. Global Fibroblast Growth Factor Receptor 4 Sales Share by Type (2021-2026)
Table 33. Global Fibroblast Growth Factor Receptor 4 Sales by Application (2015-2020) (K Pcs)
Table 34. Global Fibroblast Growth Factor Receptor 4 Sales Share by Application (2015-2020)
Table 35. Global Fibroblast Growth Factor Receptor 4 Sales Share by Application (2021-2026)
Table 36. Global Fibroblast Growth Factor Receptor 4 Sales Market Share Forecast by Application (2021-2026)
Table 37. Global Fibroblast Growth Factor Receptor 4 Revenue by Application (2015-2020) (US$ Million)
Table 38. Global Fibroblast Growth Factor Receptor 4 Revenue Market Share Forecast by Application (2021-2026)
Table 39. Japan Fibroblast Growth Factor Receptor 4 Sales (K Pcs) of Key Companies (2015-2020)
Table 40. Japan Fibroblast Growth Factor Receptor 4 Sales Share by Company (2015-2020)
Table 41. Japan Fibroblast Growth Factor Receptor 4 Revenue (US$ Million) by Company (2015-2020)
Table 42. Japan Fibroblast Growth Factor Receptor 4 Sales (K Pcs) by Type (2015-2020)
Table 43. Japan Fibroblast Growth Factor Receptor 4 Sales Share by Type (2015-2020)
Table 44. Japan Fibroblast Growth Factor Receptor 4 Revenue (US$ Million) Market Share by Type (2015-2020)
Table 45. Japan Fibroblast Growth Factor Receptor 4 Price (K Pcs) by Type (2015-2020)
Table 46. Japan Fibroblast Growth Factor Receptor 4 Sales (K Pcs) by Type (2021-2026)
Table 47. Japan Fibroblast Growth Factor Receptor 4 Sales Share by Type (2021-2026)
Table 48. Japan Fibroblast Growth Factor Receptor 4 Revenue (US$ Million) Market Share by Type (2021-2026)
Table 49. Japan Fibroblast Growth Factor Receptor 4 Revenue Share by Type (2021-2026)
Table 50. Japan Fibroblast Growth Factor Receptor 4 Price (K Pcs) by Type (2021-2026)
Table 51. Japan Fibroblast Growth Factor Receptor 4 Sales (K Pcs) by Application (2015-2020)
Table 52. Japan Fibroblast Growth Factor Receptor 4 Sales Share by Application (2015-2020)
Table 53. Japan Fibroblast Growth Factor Receptor 4 Revenue (US$ Million) Market Share by Application (2015-2020)
Table 54. Japan Fibroblast Growth Factor Receptor 4 Sales (K Pcs) by Application (2021-2026)
Table 55. Japan Fibroblast Growth Factor Receptor 4 Sales Share by Application (2021-2026)
Table 56. Japan Fibroblast Growth Factor Receptor 4 Revenue (US$ Million) Market Share by Application (2021-2026)
Table 57. Japan Fibroblast Growth Factor Receptor 4 Revenue Share by Application (2021-2026)
Table 58. North America Fibroblast Growth Factor Receptor 4 Sales by Country (2015-2020) (K Pcs)
Table 59. North America Fibroblast Growth Factor Receptor 4 Sales Market Share by Country (2015-2020)
Table 60. North America Fibroblast Growth Factor Receptor 4 Revenue by Country (2015-2020) (US$ Million)
Table 61. North America Fibroblast Growth Factor Receptor 4 Revenue Market Share by Country (2015-2020)
Table 62. Europe Fibroblast Growth Factor Receptor 4 Sales by Country (2015-2020) (K Pcs)
Table 63. Europe Fibroblast Growth Factor Receptor 4 Sales Market Share by Country (2015-2020)
Table 64. Europe Fibroblast Growth Factor Receptor 4 Revenue by Country (2015-2020) (US$ Million)
Table 65. Europe Fibroblast Growth Factor Receptor 4 Revenue Market Share by Country (2015-2020)
Table 66. Asia Pacific Fibroblast Growth Factor Receptor 4 Sales by Region (2015-2020) (K Pcs)
Table 67. Asia Pacific Fibroblast Growth Factor Receptor 4 Sales Market Share by Region (2015-2020)
Table 68. Asia Pacific Fibroblast Growth Factor Receptor 4 Revenue by Region (2015-2020) (US$ Million)
Table 69. Asia Pacific Fibroblast Growth Factor Receptor 4 Revenue Market Share by Region (2015-2020)
Table 70. Latin America Fibroblast Growth Factor Receptor 4 Sales by Country (2015-2020) (K Pcs)
Table 71. Latin America Fibroblast Growth Factor Receptor 4 Sales Market Share by Country (2015-2020)
Table 72. Latin Americaa Fibroblast Growth Factor Receptor 4 Revenue by Country (2015-2020) (US$ Million)
Table 73. Latin America Fibroblast Growth Factor Receptor 4 Revenue Market Share by Country (2015-2020)
Table 74. Middle East and Africa Fibroblast Growth Factor Receptor 4 Sales by Country (2015-2020) (K Pcs)
Table 75. Middle East and Africa Fibroblast Growth Factor Receptor 4 Sales Market Share by Country (2015-2020)
Table 76. Middle East and Africa Fibroblast Growth Factor Receptor 4 Revenue by Country (2015-2020) (US$ Million)
Table 77. Middle East and Africa Fibroblast Growth Factor Receptor 4 Revenue Market Share by Country (2015-2020)
Table 78. Amgen Inc Corporation Information
Table 79. Amgen Inc Description and Business Overview
Table 80. Amgen Inc Fibroblast Growth Factor Receptor 4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 81. Amgen Inc Fibroblast Growth Factor Receptor 4 Product
Table 82. Amgen Inc Recent Development
Table 83. ArQule Inc Corporation Information
Table 84. ArQule Inc Description and Business Overview
Table 85. ArQule Inc Fibroblast Growth Factor Receptor 4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 86. ArQule Inc Product
Table 87. ArQule Inc Recent Development
Table 88. AstraZeneca Plc Corporation Information
Table 89. AstraZeneca Plc Description and Business Overview
Table 90. AstraZeneca Plc Fibroblast Growth Factor Receptor 4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 91. AstraZeneca Plc Product
Table 92. AstraZeneca Plc Recent Development
Table 93. Blueprint Medicines Corp Corporation Information
Table 94. Blueprint Medicines Corp Description and Business Overview
Table 95. Blueprint Medicines Corp Fibroblast Growth Factor Receptor 4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 96. Blueprint Medicines Corp Product
Table 97. Blueprint Medicines Corp Recent Development
Table 98. Bristol-Myers Squibb Co Corporation Information
Table 99. Bristol-Myers Squibb Co Description and Business Overview
Table 100. Bristol-Myers Squibb Co Fibroblast Growth Factor Receptor 4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 101. Bristol-Myers Squibb Co Product
Table 102. Bristol-Myers Squibb Co Recent Development
Table 103. Eisai Co Ltd Corporation Information
Table 104. Eisai Co Ltd Description and Business Overview
Table 105. Eisai Co Ltd Fibroblast Growth Factor Receptor 4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 106. Eisai Co Ltd Product
Table 107. Eisai Co Ltd Recent Development
Table 108. Eli Lilly and Co Corporation Information
Table 109. Eli Lilly and Co Description and Business Overview
Table 110. Eli Lilly and Co Fibroblast Growth Factor Receptor 4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 111. Eli Lilly and Co Product
Table 112. Eli Lilly and Co Recent Development
Table 113. Genosco Inc Corporation Information
Table 114. Genosco Inc Description and Business Overview
Table 115. Genosco Inc Fibroblast Growth Factor Receptor 4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 116. Genosco Inc Product
Table 117. Genosco Inc Recent Development
Table 118. H3 Biomedicine Inc Corporation Information
Table 119. H3 Biomedicine Inc Description and Business Overview
Table 120. H3 Biomedicine Inc Fibroblast Growth Factor Receptor 4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 121. H3 Biomedicine Inc Product
Table 122. H3 Biomedicine Inc Recent Development
Table 123. Incyte Corp Corporation Information
Table 124. Incyte Corp Description and Business Overview
Table 125. Incyte Corp Fibroblast Growth Factor Receptor 4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 126. Incyte Corp Product
Table 127. Incyte Corp Recent Development
Table 128. Ionis Pharmaceuticals Inc Corporation Information
Table 129. Ionis Pharmaceuticals Inc Description and Business Overview
Table 130. Ionis Pharmaceuticals Inc Fibroblast Growth Factor Receptor 4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 131. Ionis Pharmaceuticals Inc Product
Table 132. Ionis Pharmaceuticals Inc Recent Development
Table 133. Johnson & Johnson Corporation Information
Table 134. Johnson & Johnson Description and Business Overview
Table 135. Johnson & Johnson Fibroblast Growth Factor Receptor 4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 136. Johnson & Johnson Product
Table 137. Johnson & Johnson Recent Development
Table 138. Merrimack Pharmaceuticals Inc Corporation Information
Table 139. Merrimack Pharmaceuticals Inc Description and Business Overview
Table 140. Merrimack Pharmaceuticals Inc Fibroblast Growth Factor Receptor 4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 141. Merrimack Pharmaceuticals Inc Product
Table 142. Merrimack Pharmaceuticals Inc Recent Development
Table 143. NGM Biopharmaceuticals Inc Corporation Information
Table 144. NGM Biopharmaceuticals Inc Description and Business Overview
Table 145. NGM Biopharmaceuticals Inc Fibroblast Growth Factor Receptor 4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 146. NGM Biopharmaceuticals Inc Product
Table 147. NGM Biopharmaceuticals Inc Recent Development
Table 148. Novartis AG Corporation Information
Table 149. Novartis AG Description and Business Overview
Table 150. Novartis AG Fibroblast Growth Factor Receptor 4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 151. Novartis AG Product
Table 152. Novartis AG Recent Development
Table 153. Principia Biopharma Inc Corporation Information
Table 154. Principia Biopharma Inc Description and Business Overview
Table 155. Principia Biopharma Inc Fibroblast Growth Factor Receptor 4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 156. Principia Biopharma Inc Product
Table 157. Principia Biopharma Inc Recent Development
Table 158. Tasly Pharmaceutical Group Co Ltd Corporation Information
Table 159. Tasly Pharmaceutical Group Co Ltd Description and Business Overview
Table 160. Tasly Pharmaceutical Group Co Ltd Fibroblast Growth Factor Receptor 4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 161. Tasly Pharmaceutical Group Co Ltd Product
Table 162. Tasly Pharmaceutical Group Co Ltd Recent Development
Table 163. Vichem Chemie Research Ltd Corporation Information
Table 164. Vichem Chemie Research Ltd Description and Business Overview
Table 165. Vichem Chemie Research Ltd Fibroblast Growth Factor Receptor 4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 166. Vichem Chemie Research Ltd Product
Table 167. Vichem Chemie Research Ltd Recent Development
Table 168. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 169. Key Challenges
Table 170. Market Risks
Table 171. Main Points Interviewed from Key Fibroblast Growth Factor Receptor 4 Players
Table 172. Fibroblast Growth Factor Receptor 4 Customers List
Table 173. Fibroblast Growth Factor Receptor 4 Distributors List
Table 174. Research Programs/Design for This Report
Table 175. Key Data Information from Secondary Sources
Table 176. Key Data Information from Primary Sources
List of Figures
Figure 1. Fibroblast Growth Factor Receptor 4 Product Picture
Figure 2. Global Fibroblast Growth Factor Receptor 4 Sales Market Share by Type in 2020 & 2026
Figure 3. BLU-9931 Product Picture
Figure 4. BMS-986036 Product Picture
Figure 5. Erdafitinib Product Picture
Figure 6. ES-135 Product Picture
Figure 7. FGF-401 Product Picture
Figure 8. Others Product Picture
Figure 9. Global Fibroblast Growth Factor Receptor 4 Sales Market Share by Application in 2020 & 2026
Figure 10. Breast Cancer
Figure 11. Lymphoma
Figure 12. Melanoma
Figure 13. Fallopian Tube Cancer
Figure 14. Lung Cancer
Figure 15. Others
Figure 16. Fibroblast Growth Factor Receptor 4 Report Years Considered
Figure 17. Global Fibroblast Growth Factor Receptor 4 Market Size 2015-2026 (US$ Million)
Figure 18. Global Fibroblast Growth Factor Receptor 4 Sales 2015-2026 (K Pcs)
Figure 19. Global Fibroblast Growth Factor Receptor 4 Market Size Market Share by Region: 2020 Versus 2026
Figure 20. Global Fibroblast Growth Factor Receptor 4 Sales Market Share by Region (2015-2020)
Figure 21. Global Fibroblast Growth Factor Receptor 4 Sales Market Share by Region in 2019
Figure 22. Global Fibroblast Growth Factor Receptor 4 Revenue Market Share by Region (2015-2020)
Figure 23. Global Fibroblast Growth Factor Receptor 4 Revenue Market Share by Region in 2019
Figure 24. Global Fibroblast Growth Factor Receptor 4 Sales Share by Manufacturer in 2019
Figure 25. The Top 10 and 5 Players Market Share by Fibroblast Growth Factor Receptor 4 Revenue in 2019
Figure 26. Fibroblast Growth Factor Receptor 4 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Fibroblast Growth Factor Receptor 4 Sales Market Share by Type (2015-2020)
Figure 28. Global Fibroblast Growth Factor Receptor 4 Sales Market Share by Type in 2019
Figure 29. Global Fibroblast Growth Factor Receptor 4 Revenue Market Share by Type (2015-2020)
Figure 30. Global Fibroblast Growth Factor Receptor 4 Revenue Market Share by Type in 2019
Figure 31. Global Fibroblast Growth Factor Receptor 4 Market Share by Price Range (2015-2020)
Figure 32. Global Fibroblast Growth Factor Receptor 4 Sales Market Share by Application (2015-2020)
Fig
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs